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Gelatin zymograms revealed in human plasma a constant 66 kDa proteolytically active polypeptide. In most plasma sam- 
ples other major proteolytic activities were seen at M, 92000,130000 and 225000. All four proteases were Caz+-dependent 
metalloproteases and bound quantitatively to gelatin-Sepharose. Immunoblotting results indicated that the 66 kDa prot- 
ease was the human fibroblast gelatinase/type IV procollagenase and that the other three proteases were macrophage/ 
granulocyte-derived gelatinase components. The 66 kDa protease did not bind to conA- nor lentil lectin-Sepharose allow- 
ing its separation from the 92, 130 and 225 kDa proteases. During the isolation procedure the plasma gelatinase/type 
IV procollagenase t nded to form a proteolytically active spontaneous disulfide-bonded imer and a 62 kDa component 
that could also be obtained by digestion with trypsin. The same polypeptide changes occurred also in stored preparations 
of the corresponding protease isolated from fibroblast culture medium while the freshly purified protein contained only 
the 66 kDa proform. 
Gelatinase; Procollagenase, type IV; Plasma protein 
1. INTRODUCTION 
Degradation of connective tissue and basement 
membranes takes place in inflammation, tumor in- 
vasion and metastasis. Several types of enzymes 
that degrade different extracellular matrix com- 
ponents have been implicated in these events. 
Among them are the metalloproteases, uch as col- 
lagenase (matrix metalloendoprotease-1; MMP-1; 
nomenclature in [l]), gelatinase (MMP-2) and 
stromelysin (MMP-3). Especially degradation of 
type IV collagen has been in the focus of interest 
and activity of enzymes capable of degrading this 
major basement membrane component have been 
correlated with metastatic potential of tumor cells 
in various in vitro tests (for references ee [2]). One 
of the best characterized extracellular matrix- 
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degrading enzymes is a gelatinase/type IV pro- 
collagenase [3] that apart from many malignant 
cultured cell types is also produced by a variety of 
normal cells [3,4]. Under nonreducing conditions 
in SDS-PAGE this enzyme has a proenzyme form 
of 66 kDa that can be activated to a 62 kDa com- 
ponent capable of degrading type IV collagen [3,5]. 
A metalloprotease that may be involved in tissue 
destruction in inflammatory conditions is the 
macrophage/granulocyte gelatinase [6-121. The 
macrophage gelatinase is composed of two poly- 
peptides of 225 and 92 kDa [13] whereas the 
granulocyte one contains an additional immuno- 
logically cross-reactive 130 kDa component 
[12,13]. 
The actual significance of these metalloproteases 
is not known and so far they have not been iden- 
tified in any defined in vivo situation. We now 
show that the 66 kDa gelatinase/type IV pro- 
collagenase is a fairly regular constituent of normal 
human plasma suggesting an in vivo role for the en- 
zyme. 
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2. MATERIALS AND METHODS 3. RESULTS AND DISCUSSION 
2.1. Plasma and proteins 
Whole blood was obtained from healthy donors and clotting 
was prevented by 0.38% sodium citrate. Plasma was separated 
from blood cells by centrifugation and stored at -20°C until 
analysed. Gelatin-binding proteins were isolated from plasma 
by gelatin-Sepharose 4B (Pharmacia, Uppsala, Sweden; [14]). 
The bound material was eluted with electrophoresis sample buf- 
fer with or without 2-mercaptoethanol, In some experiments the 
gelatin-Sepharose bound proteins were eluted with 8 M urea and 
dialysed in PBS (0.01 M sodium phosphate, 0.14 M sodium 
chloride, pH 7.4) supplemented with Ca” and Mg2+ and then 
applied to conA- or lentil lectin-Sepharose (Pharmacia) columns 
equilibrated with the same buffer. Lectin-Sepharose-bound 
material was eluted with 400 mM methyl-cr-D-manno- 
pyranoside (Calbiochem, La Jolla, CA). In a set of experiments 
2 ~1 of aliquots of plasma (in 40 ~1 of PBS) were treated with 
gelatin-, conA- or lentil 1ectinSepharoses (vol. 20 ~1). After 1 h 
incubation at room temperature with gentle mixing the gelatin- 
Sepharoses were washed three times with I ml vols.of 50 mM 
Tris-HCl, pH 7.5, or with various concentrations of NaCl or 
urea (in the same buffer) as indicated using a l-h incubation in 
each washing. The lectin-Sepharoses were similarly incubated 
and washed with PBS. The material which was still bound to 
Sepharoses after washing was then eluted with electrophoresis 
sample buffer. The fibroblast gelatinaseltype IV procollagenase 
was isolated by gelatin-Sepharose from serum-free fibroblast 
culture medium as previously described [3,4]. Before gelatin- 
Sepharose experiments, the starting materials were pretreated 
with unconjugated Sepharose 4B to remove nonspecifically 
binding proteins. Digestion with trypsin (180 U/mg; Wor- 
thington, England) was performed at 37°C for 1 h with 1 U/ml 
of the enzyme. 
Gelatin zymograms of nonreduced proteins from 
2 ~1 aliquots of different human plasma samples 
revealed a constant major proteolytically active 
66 kDa polypeptide (fig.lA). Additional major ac- 
tive polypeptides were detected at M, 92000, 
130 000 and 225 000. All four proteins bound quan- 
titatively to gelatin-Sepharose (fig.lB). No proteo- 
lytic activity was seen when plain Sepharose 4B- 
bound plasma proteins were analysed in gelatin 
zymograms or when gelatin-bound proteins were 
analysed reduced with 2-mercaptoethanol (not 
shown). The proteolytic activity was dependent on 
the Ca2+ present in the zymography gel incubation 
solutions and no activity was seen if EDTA was 
substituted for the ion (not shown). Inhibition was 
also obtained with l,lO-phenanthroline but not 
with N-ethylmaleimide nor phenylmethylsulfonyl 
fluoride. These experiments indicate that all pro- 
teolytically active gelatin-binding plasma proteins 
are metalloproteases. 
2.2. SDS-polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis in the presence of SDS- 
PAGE [I51 was performed using acrylamide concentration of 
3.3% in the spacer gel and 6% in the separating el. The samples 
were run nonreduced or reduced with 10% 2-mercaptoethanol. 
Zymography [12,13] was performed in SDS-PAGE using gels 
containing 2 mg/ml gelatin. After electrophoresis the gels were 
incubated either in the presence or absence of 5 mM Cazf. In 
the latter case diethylenetriaminepentaacetic acid (EDTA, 
5 mM) or 1, IO-phenanthroline (20 /g/ml) were included in the 
solutions. In a set of experiments, N-ethylmaleimide (5 mM) or 
phenylmethylsulfonyl fluoride (1 mM) were included in 
zymography gel incubation solutions. All these reagents were 
from Sigma, St. Louis, MO. 
Fig.2A shows immunoblotting of the gelatin- 
binding proteins from 100 /cl of the plasma sample 
of lane 4, fig.lA (denoted as plasma-4 in the 
following text), by anti-fibroblast gelatinase/type 
IV procollagenase serum. Immunoperoxidase reac- 
tion of the nonreduced sample (lane 1) was at M, 
66000 and of the reduced sample (lane 2) at Mr 
70000. Immunoblotting of similar samples with 
the antiserum against he macrophage/granulocyte 
gelatinase showed immunoperoxidase reactions at 
A4, 92000, 130000 and 225 000 (fig.2B, lane 1, 
nom-educed) and M, 95 000 (fig.2B, lane 2, reduc- 
ed) corresponding to the previously published poly- 
peptides of this metalloprotease [12,13]. 
2.3. Immunoblotting 
In immunoblotting [16] polypeptides separated by SDS- 
PAGE were transferred electrophoretically to nitrocellulose 
sheets (type I HAWP filter, Millipore, Bedford, MA). The poly- 
clonal rabbit antisera against human fibroblast gelatinase/type 
IV procollagenase and macrophage/granulocyte g latinase were 
as described [4,6,13]. lmmunoreactions were detected by using 
peroxidase-coupled swine anti-rabbit JgG antiserum 
(Dakopatts, Glostrup, Denmark). 
Elution of the gelatin-Sepharose-bound plasma 
metalloproteases with NaCl or urea did not result 
in satisfactory separation of any of them from each 
other. All four proteins remained bound to the 
Sepharose after washing with NaCl up to 3 M 
(fig.3A, lane 2). Washing of Sepharose particles 
with 2 M urea eluted most of the proteases except 
the 225 kDa one (lane 3) while 4-8 M urea eluted 
all the gelatin-binding proteins (lanes 4-6). How- 
ever, it was found that neither conA- nor lentil 
lectin-Sepharose bound the 66 kDa protease while 
others were retained by the Sepharoses (fig.3B, 
lanes 1 and 2). The 66 kDa protease was then 
separated from the other plasma metalloproteases 
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Fig. 1, Gelatin zymograms of plasma proteins. (A) Zymogram of 
2 ,cl aliquots of six different human plasma samples (lanes 1-6) 
run nonreduced in a 6070 gelatin-containing SDS-PAGE. (B) 
Zymogram of the same plasma sample as in A, lane 4 (plasma-4, 
lane 1); gelatin-binding fraction of the same material (lane 2); 
the nongelatin-binding fraction of the same material (lane 3). 
The numbers on the left indicate molecular masses in kDa. 
Fig.2. lmmunoblotting of plasma metalloproteases. The 
gelatin-binding proteins isolated from 100 rl of plasma-4 were 
electrophoreticahy transferred from a 6% SDS-PAGE to nitro- 
cellulose sheets that were immunoblotted by anti-human fibro- 
blast gelatinase/type IV procolIagenase (A) or anti-hu~n 
macrophage/granulocyte gelatinase (B). Lanes 1, nonreduced 
and lanes 2, reduced materials. The numbers on the left of each 
panel indicate molecular masses in kDa. 
Fig.3. Zymograms of gelatin- and lectin-Sepharose-bound plas- 
ma proteins. (A) Proteins from 2~1 of plasma-4 were treated 
with gelatin-Seph~ose (vol. 20 cl) and the elution of the bound 
proteins were tested by washing the Sepharose pellets with 
50 mM Tris-HC1, pH 7.5 (lane l), 3 M NaCl (lane 2), 2 M urea 
(lane 3), 4 M urea (lane 4), 6 M urea (lane 5) or 8 M urea (lane 
6) using 1 h incubation with each washing. The material remain- 
ing bound to gelatin-Sepharose after the washings was then 
eluted by nonreducing electrophoresis sample buffer and 
analysed in a 6oib gelatin-~ography gel. (B) Proteins from 2 ~1 
of plasma-4 were treated similarly with conA-Sepharose (lane 1) 
or lentil 1ectinSepharose (lane 2). The Sepharoses were washed 
with PBS and the bound materials were eluted and analysed in 
a gelatin zymography gei as above. The numbers on the left in- 
dicate molecular masses in kDa. 
by passing the proteins eluted from gelatin- 
Sepharose through a lentil lectin-Sepharose col- 
umn. Zymogram in fig.4 shows the 92, 130 and 
225 kDa proteases eluted from the lentil lectin- 
Sepharose with methyl-a-D-mannopyranoside 
(lane 1) and the flow-through containing frequent- 
ly three active polypeptide bands at 62, 66 and 
132 kDa (lane 2). Sometimes the 66 kDa protease 
was obtained intact in the lentil lectin-Sepharose 
flow-through as shown in lane 3. Treatment of this 
material with trypsin resulted in the formation of 
the 62 kDa active polypeptide (lane 4). 
The three polypeptides or occasionally two of 
them were frequently seen also in fibroblast 
gelatinase/type IV procollagenase preparations 
that were stored for up to several months and had 
been freezed and thawed several times (fig.5, lanes 
1 and 2). In immunoblotting all these three active 
polypeptides reacted with anti-fibroblast 
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Fig.4. Zymograms of isolated plasma metalloproteases. 
Gelatin-binding proteins isolated from plasma-4 were passed 
through a lentil lectin-Sepharose column. Lanes: 1, the material 
eluted with methyl+-D-mannopyranoside from the lentil lectin- 
Sepharose; 2, the lentil lectin-nonbound material; 3, another 
preparation of lentil lectin-nonbound material; 4, the material 
of lane 3 treated with trypsin. The numbers on the left indicate 
molecular masses in kDa. 
gelatinaseitype IV procollagenase serum (fig.5, 
lanes 3 and 4). Immunoperoxidase reaction of the 
reduced material of lane 2 showed only one poly- 
peptide band at 70 kDa (fig.5, lane 5) suggesting 
that the 132 kDa polypeptide was a dimer of the 
66 kDa protease. Fig.& lane 6 shows that fibro- 
blast gelatinaseitype IV procollagenase isolated 
freshly by using gelatin-Sepharose only, contained 
a single 66 kDa polypeptide. Thus, the 66 kDa 
gelatinaseitype IV procollagenase spontaneously 
forms a disulfide-bonded dimer during storage or 
more complicated isolation procedure. Further- 
more, under the same conditions the protease may 
undergo partial cleavage to the 62 kDa form that 
corresponds to the activated type IV collagenase [5] 
that can be obtained by treatment with trypsin as 
reported earlier [ 171. 
The origin of the 66 kDa protease in plasma is 
difficult to ascertain since it is secreted by various 
Fig.5. Zymograms and immunoblottings of fibroblast 
gelatinasejtype IV collagenase. Zymograms of two preparations 
of human fibroblast gelatinasejtype IV procollagenase isolated 
from serum-free fibroblast culture medium by gelatin- 
Sepharose and stored for several months (lanes 1 and 2), im- 
munoblotting of the nonreduced material shown in lane 1 (lane 
3) and in lane 2 (lane 4) with anti-fibroblast gelatinase/type IV 
procollagenase serum. Lane 5 shows the material of lane 2 im- 
munoblotted reduced. Lane 6, preparation of human fibroblast 
gelatinase/type IV procollagenase isolated freshly from serum- 
free fibroblast culture medium by gelatin-Sepharose. The 
numbers on the left indicate molecular masses in kDa. 
normal and malignant cultured cells [3,4]. Several 
lines of evidence speak for its involvement in the 
degradation of basement membranes during tumor 
invasion (for references ee [2]). The protease has 
been shown to be secreted by H-ras oncogene- 
transformed human bronchial epithelial cells but 
not by their normal counterparts [3]. Furthermore, 
the secretion of the protease in human fibroblasts 
is increased by transforming growth factor-p [ 181. 
According to the amino acid sequence data the pro- 
tease appears to be identical to the type IV pro- 
collagenase from human melanoma cells ([3,5], our 
unpublished results). 
While the expression of the 66 kDa 
gelatinase/type IV procollagenase seems to be con- 
nected with malignant transformation and tumor 
invasion, its significance in plasma of healthy 
donors is unknown. It would, however, be impor- 
tant to find out whether the quantity of the pro- 
tease in plasma would change as a reflection of any 
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physiologic or pathologic situation. Obviously the 
same concerns the macrophage/granulocyte 
gelatinase and its presence in plasma. Macrophages 
and granulocytes are not believed to function in 
blood but it is possible that these cells secrete the 
protease during their invasion and phagocytic ac- 
tion in tissues, Then it may leak into plasma where 
it could be measured by ELISA technique as 
described recently [19]. While the present results 
suggest an in vivo role for the 
macrophage/granulocyte gelatinase and human 
fibroblast gelatinaseitype IV (pro)collagenase, fur- 
ther studies are needed to elucidate their potential 
significance for instance in the diagnosis or 
monitoring of pathologic conditions, such as in- 
flammation or malignancies. 
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